According to the results of a phase 1 clinical trial just published in STEM CELLS Translational Medicine, a new stem cell therapy shows promise of making diabetes-related amputations a thing of the past. The trial involved injecting diabetes patients suffering from non-healing diabetic foot ulcers (DFU) with a cell preparation containing adult stem cells harvested from their own fat. The results showed that the treatment induced regeneration of the blood vessels surrounding the DFUs, accelerated healing – all with no serious side effects.
“Non-healing diabetic foot ulcers usually have no effective form of treatment,” said Anthony Atala, M.D., Editor-in-Chief ofSTEM CELLS Translational Medicineand Director of the Wake Forest Institute for Regenerative Medicine. “This work should be reviewed as it demonstrates the possibility of a novel cell injection therapy that can alleviate pain and infection, accelerate wound healing, and possibly avoid amputation.”
Worldwide, every 30 seconds a leg…
View original post 936 more words